This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live
The Alabama Medical Cannabis Commission (AMCC) has confirmed that it has rescinded 90 previous medical cannabis business license awards and denials in order to carry out new procedures adopted under emergency rules.
The new licensing rules were adopted following legal battles in the state over the AMCC’s decision process.
The new rules retain the previous score results, however, they also provide licence applicants to present to the Commission on issues pertaining to their applications and scores.
AMCC Chairman Rex Vaughn stated: “This action paves a path for us to award business licenses by the end of the year.
“We have an aggressive timeline in front of us, but we feel that it is of the utmost importance that we get this industry started in an expeditious manner for both the applicants and patients.”
The AMCC has now begun accepting public comments for or against the granting of particular licenses, with applicants able to submit “exhibits that were not previously filed due to the file size limitation in the application portal.”
Vaughn added: “The Commission’s rules are clear that the Commission has full discretion as to license award decisions.
“Rule 538-x-3-.12 states in part that, ‘the Commission remains the primary decisionmaker with regard to licensing and has authority to act independently of any third-party evaluation and recommendation.
The AMCC has stated that it is scheduled to award cultivator, processor, dispensary, secure transporter, and state testing laboratory licenses on December 1, 2023 and award integrated facility licenses on December 12, 2023.
